This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Purisys, Inc., Noramco Gmbh. Active years: 2018-2024.
Company Filing History:
Years Active: 2018-2024
Title: Denis Petrovic: Innovator in Cannabidiol Research
Introduction
Denis Petrovic is a notable inventor based in Schaffhausen, Switzerland. He has made significant contributions to the field of cannabinoid research, particularly in the development of highly pure cannabidiol compounds. With a total of 3 patents to his name, Petrovic's work is paving the way for advancements in cannabinoid applications.
Latest Patents
Petrovic's latest patents include innovative methods for producing cannabidiol compositions with modified cannabinoid profiles. One of his notable patents describes a novel synthesis route for a highly pure cannabidiol compound. This compound is prepared through an acid-catalyzed reaction of a di-halo olivetol with menthadienol, followed by two crystallization steps. The resulting cannabidiol compound exhibits high yield and stereospecificity, while maintaining exceedingly low levels of Δ-9-tetrahydrocannabinol during preparation and storage. Another patent focuses on the production processes for cannabidiol and delta-9-tetrahydrocannabinol, utilizing a similar acid-catalyzed reaction to produce dibromo-cannabidiol compounds.
Career Highlights
Throughout his career, Denis Petrovic has worked with reputable companies in the cannabinoid industry, including Purisys, Inc. and Noramco GmbH. His experience in these organizations has allowed him to refine his expertise in cannabinoid synthesis and applications.
Collaborations
Petrovic has collaborated with notable colleagues such as Ulrich Weigl and Lukas Dialer. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Denis Petrovic is a prominent figure in the field of cannabinoid research, with a focus on the synthesis of highly pure cannabidiol compounds. His innovative patents and collaborations highlight his commitment to advancing cannabinoid applications.
